Selective formation of certain advanced glycation end products in spinal cord astrocytes of humans and mice with superoxide dismutase-1 mutation

Acta Neuropathologica

Volumn 104, Issue 2, 2002, Pages 171-178

  Shibata, Noriyuki ^a   Hirano, Asao ^b   Hedley Whyte, E Tessa ^c   Dal Canto, Mauro C ^d   Nagai, Ryoji ^e   Uchida, Koji ^f   Horiuchi, Seikoh ^e   Kawaguchi, Motoko ^a   Yamamoto, Tomoko ^a   Kobayashi, Makio ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^f NAGOYA UNIVERSITY   (Japan)

Author keywords

Advanced glycation end products; Amyotrophic lateral scalerosis; Astrocyte; Superoxide dismutase; Transgenic mice

Indexed keywords

4 HYDROXYNONENAL; 6 N CARBOXYETHYLLYSINE; 6 N CARBOXYMETHYLLYSINE; ACROLEIN; ADVANCED GLYCATION END PRODUCT; ARGPYRIMIDINE; CARBONYL DERIVATIVE; HISTIDINE; LIPID; LYSINE; MALONALDEHYDE; PENTOSIDINE; PYRIMIDINE DERIVATIVE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL DISEASE; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPID OXIDATION; MALE; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; SPINAL CORD; SPINAL CORD MOTONEURON; TRANSGENIC MOUSE;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ASTROCYTES; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALE; MICE; MICE, TRANSGENIC; MIDDLE AGED; MUTATION; SPINAL CORD; SUPEROXIDE DISMUTASE;

EID: 0036938699     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-002-0537-5     Document Type: Article

References (52)

1. Andersen PM, Morita M, Brown RH Jr (2000) Genetics of amyotrophic lateral sclerosis: an overview. In: Brown RH Jr, Meininger V, Swash M (eds) Amyotrophic lateral sclerosis. Martin Dunitz, London, pp 223-250
2. Bendotti C, Tortarolo M, Suchak SK, Calvaresi N, Carvelli L, Bastone A, Rizzi M, Rattray M, Mennini T (2001) Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels. J Neurochem. 79:737-746
3. Blanc EM, Keller JN, Fernandez S, Mattson MP (1997) 4-Hydroxynonenal, a lipid peroxidation product, impairs glutamate transport in cortical astrocytes. Glia 22:149-160
4. Bruijn LI, Becher MW, Lee MK, Anderson KL, Jenkins NA, Copeland NG, Sisodia SS, Rothstein JD, Borchelt DR, Price DL, Cleveland DW (1997) ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18:327-338
5. Calingasan NY, Uchida K, Gibson GE (1999) Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease. J Neurochem 72:751-756
6. Camandola S, Scavazza A, Leonarduzzi G, Biasi F, Chiarpotto E, Azzi A, Poli G (1997) Biogenic 4-hydroxy-2-nonenal activates transcription factor AP-1 but not NF-κB in cells of the macrophage lineage. Biofactors 6:173-179
7. Castellani R, Smith MA, Richey PL, Perry G (1996) Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Brain Res 737:195-200
8. Cudkowicz ME, McKenna-Yasek D, Chen C, Hedley-Whyte ET, Brown RH Jr (1998) Limited corticospinal tract involvement in amyotrophic lateral sclerosis subjects with the A4V mutation in the copper/zinc superoxide dismutase gene. Ann Neurol 43:703-710
9. Dal Canto MC, Mourelatos Z, Gonatas NK, Chiu A, Gurney ME (1996) Neuropathological changes depend on transgene copy numbers in transgenic mice for mutant human Cu,Zn superoxide dismutase (SOD). In: Nakano I, Hirano A (eds) ICS-1104, amyotrophic lateral sclerosis: progress and perspectives in basic research and clinical application. Elsevier, Amsterdam, pp 331-338
10. Esterbauer H, Schaur RJ, Zollner H (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11:81-128
11. Ferrante RJ, Browne SE, Shinobu LA, Bowling AC, Baik MJ, MacGarvey U, Kowall NW, Brown RH Jr, Beal MF (1997) Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochm 69:2064-2074
12. Fitzmaurice PS, Shaw IC, Kleiner HE, Miller RT, Monks TJ, Lau SS, Mitchell JD, Lynch PG (1996) Evidence for DNA damage in amyotrophic lateral sclerosis. Muscle Nerve 19: 797-798
13. Friguet B, Szweda LI (1997) Inhibition of the multicatalytic proteinase (proteasome) by 4-hydroxy-2-nonenal cross-linked protein. FEBS Lett 405:21-25
14. ε-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem 271:9982-9986
15. Hayase F, Shibuya T, Sato J, Yamamoto M (1996) Effects of oxygen and transtion metals on the advanced Maillard reaction of proteins with glucose. Biosci Biotech Biochem 60 (Suppl 2): S63-S66
16. Keller JN, Kindy MS, Holtsberg FW, St. Clair DK, Yen H-C, Germeyer A, Steiner SM, Bruce-Keller AJ, Hutchins JB, Mattson MP (1998) Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: supression of mitochondrial dysfunction. J Neurosci 18: 687-697
17. Kikuchi S, Shinpo K, Morikawa F, Makita Z, Miyata T, Tashiro K (1999) Neurotoxicity of methylglyoxal and 3-deoxyglucosone on cultured cortical neurons: synergism between glycation and oxidative stress, possibly involved in neurodegenerative diseases. J Neurosci Res 57:280-289
18. Kimura T, Ikeda K, Takamatsu J, Miyata T, Sobue G, Miyakawa T, Horiuchi S (1996) Identification of advanced glycation end products of the Maillard. reaction in Pick's disease. Neurosci Lett 219:95-98
19. Kozlovsky N, Rudich A, Potashnik R, Ebina Y, Murakami T, Bashan N (1997) Transcriptional activation of the Glut1 gene in response to oxidative stress in L6 myotubes. J Biol Chem 272:33367-33372
20. Kruman I, Bruce-Keller AJ, Bredesen D, Waeg G, Mattson MP (1997) Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J Neurosci 17:5089-5100
21. Kumagai T, Kawamoto Y, Nakamura Y, Hatayama I, Satoh K, Osawa T, Uchida K (2000) 4-Hydroxy-2-nonenal, the end product of lipid peroxidation, is a specific inducer of cyclooxygenase-2 gene expression. Biochem Biophys Res Commun 273:437-441
22. Kuo CL, Vaz AD, Coon MJ (1997) Metabolic activation of trans-4-hydroxy-2-nonenal, a toxic products of membrane lipid peroxidation and inhibitor of P450 cytochromes. J Biol Chem 272:22611-22616
23. Lovell MA, Ehmann WD, Mattson MP, Markesbery WR (1995) Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol Aging 18:457-461
24. Mark RJ, Lovell MA, Markesbery WR, Uchida K, Mattson MP (1997) A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J Neurochem. 68: 255-264
25. Mark RJ, Pang Z, Geddes JW, Uchida K, Mattson MP (1997) Amyloid β-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J Neurosci 17:1046-1054
26. Miyata T, De Strihou C van Y, Kurokawa K, Baynes JW (1999) Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications. Kidney Int 55:389-399
27. Montine TJ, Amarnath V, Martin ME, Strittmatter WJ, Graham DG (1996) E-4-Hydroxy-2-nonenal is cytotoxic and crosslinks cytoskeletal proteins in P19 neuroglial cultures. Am J Pathol 148:89-93
28. Montine KS, Kim PJ, Olson SJ, Markesbery WR, Montine TJ (1997) 4-Hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease. J Neuropathol Exp Neurol 56:866-871
29. ε-(carboxymethyl)lysine formation from Amadori product. Biochem Biophys Res Commun 234:167-172
30. ε-(carboxymethyl)lysine, an advanced glycation end product, by glyoxal and 3-deoxyglucosone in cultured rat sensory neurons. Biochem Biophys Res Commun 248:93-97
31. Okado A, Kawasaki Y, Hasuike Y, Takahashi M, Teshima T, Fujii J, Taniguchi N (1996) Induction of apoptotic cell death by methyglyoxal and 3-deoxyglucosone in macrophage-derived cell lines. Biochem Biophys Res Commun 225:219-224
32. Oya T, Hattori N, Mizuno Y, Miyata S, Maeda S, Osawa T, Uchida K (1999) Methylglyoxal modification of protein. J Biol Chem 274:18492-18502
33. Pedersen WA, Fu W, Keller JN, Markesbery WR, Appel S, Smith RG, Kasarskis E, Mattson MP (1998) Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Ann Neurol 44:819-824
34. Pedersen WA, Cashman NR, Mattson MP (1999) The lipid peroxidation product of 4-hydroxynonenal impairs glutamate and glucose transport and choline acetyltransferase activity in NSC-19 motor neuron cells. Exp Neurol 44:1-10
35. Rothstein JD, Kammen M van, Levey AI, Martin LJ, Kuncl RW (1995) Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis Ann Neurol 38:73-84
36. Shaw PJ, Ince PG, Falkous G, Mantle D (1995) Oxidative damage to protein in sporadic motor neuron disease spinal cord. Ann Neurol 38:691-695
37. Shibata N (2001) Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation. Neuropathology 21:82-92
38. Shibata N, Hirano A, Kobayashi M, Siddique T, Deng H-X, Hung W-Y, Kato T, Asayama K (1996) Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J Neuropathol Exp Neurol 55:481-490
39. Shibata N, Nagai R, Miyata S, Jono T, Horiuchi S, Hirano A, Kato S, Sasaki S, Asayama K, Kobayashi M (2000) Nonoxidative protein glycation is implicated in familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation. Acta Neuropathol 100:275-284
40. Shibata N, Hirano A, Yamamoto T, Kato Y, Kobayashi M (2000) Superoxide dismutase-1 mutation-related neurotoxicity in familial amyotrophic lateral sclerosis. ALS 1:143-161
41. Shibata N, Nagai R, Uchida K, Horiuchi S, Yamada S, Hirano A, Kawaguchi M, Yamamoto T, Sasaki S, Kobayashi M (2001) Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients. Brain Res 917:97-104
42. Shinpo K, Kikuchi S, Sasaki H, Ogata A, Morikawa F, Tashiro K (2000) Selective vulnerability of spinal motor neurons to reactive dicarbonyl compounds, intermediate products of glycation, in vitro: implication of inefficient glutathione system in spinal motor neurons. Brain Res 861:151-159
43. Takizawa N, Takada K, Ohkawa K (1993) Inhibitory effect of nonenzymatic glycosylation on ubiquitination and ubiquitin-mediated degradatio of lysozyme. Biochem Biophys Res Commun 192:700-706
44. Thornalley PJ, Langborg A, Minhas H (1999) Formation of glyoxal, methyglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J 344:109-116
45. Toyokuni S, Miyake N, Hiai H, Hagiwara M, Kawakishi S, Osawa T, Uchida K (1995) The monoclonal antibody specific for the 4-hydroxy-2-nonenal histidine adduct. FEBS Lett 259: 189-191
46. Uchida K, Kanematsu M, Sakai K, Matsuda T, Hattori N, Mizuno Y, Suzuki D, Miyata T, Noguchi N, Niki E, Osawa T (1998) Protein-bound acrolein: potential markers for oxidative stress. Proc Natl Acad Sci USA 95:4882-4887
47. Uchida K, Shiraishi M, Naito Y, Torii Y, Nakamura Y, Osawa T (1999) Activation of stress signaling pathways by the end product of lipid peroxidation. J Biol Chem 274:2234-2242
48. Wells-Knecht KJ, Zyzak DV, Litchfield JE, Thorpe SR, Baynes JW (1995) Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry 34:3702-3709
49. Yamada S, Kumazawa S, Ishii T, Nakayama T, Itakura K, Shibata N, Kobayashi M, Sakai K, Osawa T, Uchida K (2001) Immunochemical detection of a lipofuscin-like fluorophore derived from malondialdehyde and lysine. J Lipid Res 42:1187-1196
50. Yan SD, Yan SF, Chen X, Fu J, Chen M, Kuppusamy P, Smith MA, Perry G, Godman GC, Nawroth P, Zweier JL, Stern D (1995) Non-enzymatic glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide. Nat Med 1:693-699
51. Yan SD, Zhu H, Fu J, Yan SF, Rother A, Tourtellotte WW, Rajavashisth T, Chen X, Godman GC, Stern D, Schmidt AM (1997) Amyloid β-peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc Natl Acad Sci USA 94:5296-5301
52. Yoritaka A, Hattori N, Uchida K, Tanaka M, Stadtman ER, Mizuno M (1996) Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson's disease. Proc Natl Acad Sci USA 93:2696-2701